Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma. - Wikidata - awgldk - TriplyDB

Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.

Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q35095399

about

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma.Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma.

P2860

Q33743268-74B23B70-DC04-420A-AC47-96C2C1E95994 Q37080154-3EDA672B-2A1F-4168-A48B-6CD8F2826C1A

P2860

Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q35095399

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@ast

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@en

type

label

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@ast

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@en

prefLabel

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@ast

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@en

P1433

Q35095399-E6BA67E4-9805-4AC1-BE0B-0BC5D9C56887

P1476

Q35095399-002F5FDD-3644-4987-A345-80EB13B479BC

P2093

Q35095399-4A6BE538-8D18-412F-B52D-2E6F2E22D7A7

Q35095399-5D7778C5-60F1-4F44-9B7A-B9257D66096A

Q35095399-7A28AD85-2B99-47AF-8549-69B958B9B553

Q35095399-A0AF46B9-64A5-4442-967B-B5991FE10A66

Q35095399-B200F5F0-BF64-4F6B-9F21-9944A8F4C953

Q35095399-B4ACB2C5-084E-43B4-A79F-93A9C0A8D594

Q35095399-C3645515-FD62-437A-BA2A-D4E4220C4EAA

Q35095399-D5F608C5-E169-42E2-BDD7-8C19A8A239F2

P2860

Q35095399-09A66248-F132-4E90-BD87-EAA4D1C61852

Q35095399-1B36A356-1B5B-471D-A16D-F227FD8C15BF

Q35095399-249A11BA-61C1-4EB5-8629-87F1BEF13B88

Q35095399-2EF99557-FBC0-40B5-B5FE-2DA8F9E0030F

Q35095399-38EFBE33-8587-4F7B-A256-303D640C9618

Q35095399-3916B4C0-9C8B-49B6-9820-4946C64225E8

Q35095399-3F9A0E12-1BC6-4483-A191-D48318403715

Q35095399-4148103B-83E7-435F-93D7-4DC4DBD301BD

Q35095399-4816A64B-7043-4120-B187-9E30D37C96E3

Q35095399-4B22AF94-A229-459B-A497-3B6B118429EC

P304

Q35095399-0022900A-255F-47B0-8C7B-2DBA9A6BB061

P31

Q35095399-E5E8ED8E-D373-49E4-82E8-475834932D73

P356

Q35095399-91C129BA-352D-4C80-B7C8-684411C66ABF

P407

Q35095399-380AF645-EED3-4058-93E0-37B6FDF9F486

P433

Q35095399-FA0182BA-A875-4CE5-95A6-52F81431A423

P478

Q35095399-D1E497EF-8DA0-438D-9A19-6FA62B5541D2

P577

Q35095399-A529E1D2-B023-46B2-BB09-6AA26A1A144E

P5875

Q35095399-29B24A5E-EB3F-49A0-858A-5B42E0927E0E

P698

Q35095399-6E452988-1618-4042-BF14-ED1339071CDA

P932

Q35095399-06BA1944-0AFD-4473-A411-9FA0BD7EBC22

P356

JOURNAL.PONE.0116803

P1433

P1476

Coexpression of EGFR and CXCR4 ...... creatic ductal adenocarcinoma.

@en

P2093

Huadan Xue

http://www.w3.org/2001/XMLSchema#string

Huanwen Wu

http://www.w3.org/2001/XMLSchema#string

Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Liang Zhu

http://www.w3.org/2001/XMLSchema#string

Wenze Wang

http://www.w3.org/2001/XMLSchema#string

Xiaohua Shi

http://www.w3.org/2001/XMLSchema#string

Zhiyong Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the hedgehog pathway in advanced prostate cancer

EGF receptor is required for KRAS-induced pancreatic tumorigenesis

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.

Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes

Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.

Activation of tyrosine kinases in cancer.

CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor κB: implications for bidirectional tumor-stromal interactions.

CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

P304

e0116803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0116803

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273953307

http://www.w3.org/2001/XMLSchema#string

P698

25679210

http://www.w3.org/2001/XMLSchema#string

P932

4332630

http://www.w3.org/2001/XMLSchema#string